Shares of Bodycote plc (LON:BOY – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the six brokerages that are covering the company, Marketbeat Ratings reports. Two investment analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 12 month price objective among brokerages that have covered the stock in the last year is GBX 850.83.
Several brokerages have commented on BOY. Deutsche Bank Aktiengesellschaft upgraded shares of Bodycote to a “buy” rating and boosted their price target for the stock from GBX 835 to GBX 960 in a research report on Thursday. Royal Bank Of Canada cut shares of Bodycote to a “sector perform” rating and set a GBX 775 price target on the stock. in a research report on Thursday, March 12th. Berenberg Bank restated a “buy” rating and set a GBX 900 price objective on shares of Bodycote in a report on Thursday, March 12th. Finally, JPMorgan Chase & Co. boosted their price objective on Bodycote from GBX 670 to GBX 700 and gave the stock a “neutral” rating in a report on Thursday, March 19th.
Read Our Latest Report on Bodycote
Bodycote Price Performance
Bodycote (LON:BOY – Get Free Report) last issued its quarterly earnings results on Wednesday, March 11th. The company reported GBX 44.40 EPS for the quarter. Bodycote had a net margin of 7.55% and a return on equity of 8.58%. As a group, sell-side analysts anticipate that Bodycote will post 54.0540541 EPS for the current fiscal year.
Bodycote Company Profile
The leading provider of heat treatment and specialist thermal processing services worldwide.
Heat treatment encompasses a variety of techniques and specialist engineering processes which improve the properties of metals and alloys and extend the life of components and is a vital part of any manufacturing process.
Bodycote is uniquely placed via our global network and the experience and knowledge of our people to offer high quality, reliable and cost-effective services to manufacturers whatever their size or market sector.
See Also
- Five stocks we like better than Bodycote
- Costco’s Strong Quarter Still Leaves Investors With a Valuation Problem
- These 3 Software Stocks Are Buying Back Shares Hand Over Fist
- Gap Inc. Cuts Sales Outlook After Q1 Miss, Shares Drop 17%
- MongoDB’s AI Advantage Is Starting to Show Up in Results
Receive News & Ratings for Bodycote Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bodycote and related companies with MarketBeat.com's FREE daily email newsletter.
